Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ( EGFR -TKI) in EGFR -Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients.
Ziyi XuXuezhi HaoQi WangJing WangKe YangShouzheng WangFei TengJunling LiPuyuan XingPublished in: Cancer management and research (2022)
-mutated lung adenocarcinoma and may represent a potential treatment option for selected T790M-negative patients.